Mepolizumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
NUCALA mepolizumab 100 mg powder for injection AUST R: 232028Active ingredients:
Mepolizumab
Dosage form:
Injection, powder for
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
Deletion from market:
01 Aug 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative product by same sponsor available - NUCALA mepolizumab 100 mg solution for injection in pre-filled pen (ARTG: 317304)
|